Tuberculosis Drug Therapy
Mostrando 1-12 de 61 artigos, teses e dissertações.
-
1. Clinical diagnosis and treatment of primary thyroid tuberculosis: a retrospective study
ABSTRACT BACKGROUND: Primary thyroid tuberculosis (PTT) is an uncommon type of extrapulmonary tuberculosis, which is caused by Mycobacterium tuberculosis. It does not have specific clinical manifestations, and most cases are diagnosed through postoperative histopathological examination. OBJECTIVE: To evaluate the diagnostic pattern and management strategy
Sao Paulo Medical Journal. Publicado em: 2022
-
2. CLINICAL PROFILE, DRUG RESISTANCE PATTERN AND TREATMENT OUTCOMES OF ABDOMINAL TUBERCULOSIS PATIENTS IN WESTERN INDIA
RESUMO CONTEXTO: A tuberculose abdominal é um problema crescente no mundo em desenvolvimento. OBJETIVO: O objetivo do estudo foi descrever as apresentações clínicas, o padrão de resistência a fármacos e os desfechos de tratamento da tuberculose abdominal na Índia ocidental. MÉTODOS: Foram incluídos todos os casos de tuberculose abdominal de ma
Arq. Gastroenterol.. Publicado em: 26/08/2019
-
3. Drug therapy problems for patients with tuberculosis and HIV/AIDS at a reference hospital
RESUMO Objetivo: Determinar a frequência de problemas relacionados ao uso de medicamentos no tratamento de pacientes com tuberculose e HIV/AIDS. Métodos: Os dados foram obtidos por estudo transversal realizado entre setembro de 2015 e dezembro de 2016 em hospital referência em doenças infectocontagiosas de Belo Horizonte (MG), Brasil. As variáveis soc
Einstein (São Paulo). Publicado em: 22/08/2019
-
4. Evaluation of the impact of pharmaceutical care for tuberculosis patients in a Secondary Referral Outpatient Clinic, Minas Gerais, Brazil
ABSTRACT Pharmaceutical care is a professional practice seeking the responsible provision of drug therapy by identifying, resolving, and preventing Drug-Related Problems (DRP). The study aims to describe and evaluate the impact of pharmaceutical care given to patients being treated for tuberculosis (TB). Study concurrent, longitudinal, prospective conducted
An. Acad. Bras. Ciênc.. Publicado em: 2017-12
-
5. Efficacy and safety of a four-drug fixed-dose combination regimen versus separate drugs for treatment of pulmonary tuberculosis: a systematic review and meta-analysis
Abstract Introduction: Tuberculosis, particularly multi-drug-resistant tuberculosis, is a major cause of morbidity and mortality worldwide. To the best of our knowledge, however, no study to date has assessed the combined use of the four available drugs for tuberculosis treatment, which is an issue of great clinical relevance. Objective: To determine wheth
Braz. J. Microbiol.. Publicado em: 2017-06
-
6. Prevalence of hepatitis C virus and human immunodeficiency virus in a group of patients newly diagnosed with active tuberculosis in Porto Alegre, Southern Brazil
BACKGROUND Porto Alegre is the Brazilian state capital with second highest incidence of tuberculosis (TB) and the highest proportion of people infected with human immunodeficiency virus (HIV) among patients with TB. Hepatitis C virus (HCV) infection increases the risk of anti-TB drug-induced hepatotoxicity, which may result in discontinuation of the therap
Mem. Inst. Oswaldo Cruz. Publicado em: 2017-04
-
7. Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates
Mycobacterium tuberculosis (Mtb) has acquired resistance and consequently the antibiotic therapeutic options available against this microorganism are limited. In this scenario, the use of usnic acid (UA), a natural compound, encapsulated into liposomes is proposed as a new approach in multidrug-resistant tuberculosis (MDR-TB) therapy. Thus the aim of this st
Mem. Inst. Oswaldo Cruz. Publicado em: 29/04/2016
-
8. Research on tuberculosis: 75 years of IBIT contributions
In 1937, the foundation year of the Brazilian Institute for Tuberculosis Research, three questions persisted in the researchers' mind: "What is the real value of BCG? How to solve the problem of the chest register of large communities? When will we have a specific drug for the treatment of tuberculosis?"; Along with this line of thought, the author presents
Braz J Infect Dis. Publicado em: 2013-04
-
9. Histoplasmose pulmonar cavitária crônica simulando tuberculose / Chronic pulmonary histoplasmosis mimicking tuberculosis
Avaliar os casos de histoplasmose pulmonar crônica ocorridos nos últimos anos, atendidos no Complexo Hospitalar Santa Casa de Porto Alegre (RS). Métodos: Foram revisados os casos atendidos nos últimos 25 anos no Complexo Hospitalar Santa Casa de Porto Alegre e descritos quatro casos diagnosticados por cultivo e/ou achado histopatológico, corroborados po
Publicado em: 2010
-
10. Histoplasmose pulmonar aguda no Rio Grande do Sul / Chronic pulmonary histoplasmosis mimicking tuberculosis
Objetivo: Avaliar os casos de histoplasmose pulmonar crônica ocorridos nos últimos anos, atendidos no Complexo Hospitalar Santa Casa de Porto Alegre (RS). Métodos: Foram revisados os casos atendidos nos últimos 25 anos no Complexo Hospitalar Santa Casa de Porto Alegre e descritos quatro casos diagnosticados por cultivo e/ou achado histopatológico, corro
Publicado em: 2010
-
11. Prevalência da resistência às drogas do Mycobacterium tuberculosis associada ao tratamento auto-administrado parcialmente intermitente comparada ao tratamento diário
Background: Drug resistance relative to Mycobacterium tuberculosis is mainly due to the kind of treatment usually taken and is a problem to the therapy efficiency by itself. Objective: Compare mycobacterial resistance to drugs between two communities, one that takes partially intermittent therapy, and another that takes it daily. Methods: data from 5138 pati
Publicado em: 2009
-
12. Genetic variants of N-acetyltransferase 2, CYP2E1 and Glutathione S-transferase: relation with therapeutic safety in patients with tuberculosis / Variantes genéticas da N-acetiltransferase 2, CYP2E1 e glutationa S-transferase: relação com a segurança terapêutica em pacientes com tuberculose
Polymorphisms in N-acetiltransferase 2 (NAT2), CYP2E1 and glutatione S-transferase (GST) have been associated with differences in response to antituberculosis drugs. The role of the NAT2, CYP2E1 and GSTM1/GSTT1 variants on safety profile of the anti-tuberculosis therapy was evaluated in 99 tuberculosis patients, without co-infection by HIV or hepatitis virus
Publicado em: 2009